Announcing the appointment of Dr. Douglas Sborov as the Co-Director of the University of Utah/Huntsman Cancer Institute Multiple Myeloma Program. This appointment, in partnership with Dr. Djordje Atanackovic, is effective as of October 3, 2018 and will be ongoing. Dr. Sborov joined our faculty in the Division of Hematology and Hematologic Malignancies in August 2016 and has excelled in his role as a clinical investigator. With a large clinical practice, active clinical trials and a loyal patient base, Dr. Sborov is the perfect candidate to help our myeloma program grow to the next level! Many thanks to Doug for agreeing to step into this expanded role. We are looking forward to the many great things to come.